Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind Phase III Study of Pyridoxine vs Placebo for the Prevention of Capecitabine-induced Hand-Foot Syndrome

NCT00446147 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT00446147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00446147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind Phase III Study of Pyridoxine vs Placebo for the Prevention of Capecitabine-induced Hand-Foot Syndrome
Lead sponsor
Asan Medical Center
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2004
Completion date
December 31, 2006
Enrollment
389 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hand-foot syndrome